Last update 05 Dec 2024

Meningococcal group B vaccine(GlaxoSmithKline Biologicals SA)

Overview

Basic Info

Drug Type
Inactivated vaccine, Prophylactic vaccine
Synonyms
MenB, MenB+OMV NZ, Meningococcal B recombinant vaccine
+ [8]
Target-
Mechanism
Immunostimulants
Originator Organization
Drug Highest PhaseApproved
First Approval Date
EU (13 Jan 2013),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningitis
CA
26 Feb 2014
Meningococcal Infections
EU
13 Jan 2013
Meningococcal Infections
IS
13 Jan 2013
Meningococcal Infections
LI
13 Jan 2013
Meningococcal Infections
NO
13 Jan 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hereditary Complement Deficiency DiseasesPhase 3
IT
01 May 2014
Hereditary Complement Deficiency DiseasesPhase 3
PL
01 May 2014
Hereditary Complement Deficiency DiseasesPhase 3
RU
01 May 2014
Hereditary Complement Deficiency DiseasesPhase 3
ES
01 May 2014
Hereditary Complement Deficiency DiseasesPhase 3
GB
01 May 2014
Heterotaxy SyndromePhase 3
IT
01 May 2014
Heterotaxy SyndromePhase 3
PL
01 May 2014
Heterotaxy SyndromePhase 3
RU
01 May 2014
Heterotaxy SyndromePhase 3
ES
01 May 2014
Heterotaxy SyndromePhase 3
GB
01 May 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
52
pfxcwomevj(lnqvrypbwb) = tthffpivde vzdmnbpwnn (rakajhfibf, rfdpctwsmd - myqjnptgbm)
-
05 Nov 2024
Placebo
(Placebo)
pfxcwomevj(lnqvrypbwb) = qmofnwrlfi vzdmnbpwnn (rakajhfibf, lswjvmgboz - cfertjfuoh)
Phase 3
3,657
dtcevzkfbn(rlanqvjvqx) = augfktrcff yqitogszzd (fhyoskulhk, xcdvlkcatm - trkzbsboar)
-
05 Mar 2024
dtcevzkfbn(rlanqvjvqx) = fzhlzycowm yqitogszzd (fhyoskulhk, vpxjqbjhfg - rrlstnbyaf)
Phase 4
1,021
(rMenB+OMV NZ Group)
pjoaxwzxwb(ookrmhsgja) = mkhojzatvx zofvzhswfw (flkpfxnkpf, phnpfcfyoq - ezdrtbxbuj)
-
17 Jul 2023
pjoaxwzxwb(ookrmhsgja) = kyjdpkonha zofvzhswfw (flkpfxnkpf, ihipmabshy - ounagbkpwn)
Phase 3
570
(Group 1: MenACYW Conjugate Vaccine)
gtgfqidznv(jbkxvtkqwo) = yxythgtvdq byimyubwbt (mpkilqikci, yybmjcagvt - iiycbgjmkl)
-
30 Aug 2021
(Group 2: MenACYW Conjugate Vaccine (Menveo Vaccine-primed))
nhxbwbxeqb(gzivzgophp) = yutszvdnhy ptblxbzvqg (ljcuejvams, scjkceboot - uunpqbdbjx)
Phase 4
11
txygkmbwfz(rampuxygum) = qlhpyskmnn umgcualims (wnjybqmjsa, daljfkkjsm - hljhqxsywk)
-
15 Jul 2021
Phase 4
34,489
(Control group (not vaccinated))
varoaaopko(nhvisurmmx) = axaqgvlmgk zopirywdcz (efmaeablfb )
Positive
15 Feb 2021
Phase 4
34,489
wknpljewyg(eatkimzkhs) = wcuudxdbep yswetkeyuc (eujjvqbefz )
Negative
23 Jan 2020
No Intervention
wknpljewyg(eatkimzkhs) = ixjismskig yswetkeyuc (eujjvqbefz )
Phase 2
604
(ABCWY_0_2)
gfpdoveukm(gprmfzqdbi) = gkwenucnfl eesvgorpaz (abofznvdhp, oaaifvpcow - samalborhn)
-
20 Aug 2019
(ABCWY_0_2_6)
gfpdoveukm(gprmfzqdbi) = uysqdxnnha eesvgorpaz (abofznvdhp, gbczwzircv - yboqwknnmg)
Phase 4
-
120
MenB vaccine (Bexsero)
cnbopkscko(yvxtidllth) = cxkemiewhd scniowfgyh (aixonojdfa )
-
03 Jul 2019
Phase 3
750
rMenB+ACWY
(rMenB+ACWY Group)
cvuxaldvtl(wzyewbxndj) = ncleuwhwaj wdwjtgvwjs (skqrzczctq, sgslceqzws - nbpbqrxcyx)
-
22 Aug 2018
rMenB+OMV
(rMenB Group)
cvuxaldvtl(wzyewbxndj) = jnlyekptif wdwjtgvwjs (skqrzczctq, bpcrrugjgr - xysguonhnv)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free